首页> 外国专利> Aminoguanidinas and alcoxiguanidinas as protease inhibitors, alcoxiaminas for exclusive use in the process of obtaining such Compounds, Pharmaceutical composition,Use of such compounds and compositions for preparing Medicines, device used in the collection, circulation and storage of blood and Process for preparing such compounds.

Aminoguanidinas and alcoxiguanidinas as protease inhibitors, alcoxiaminas for exclusive use in the process of obtaining such Compounds, Pharmaceutical composition,Use of such compounds and compositions for preparing Medicines, device used in the collection, circulation and storage of blood and Process for preparing such compounds.

机译:作为蛋白酶抑制剂的氨基胍和铝制胍,在获得此类化合物的过程中专用的铝氧体,药物组合物,此类化合物和组合物在制备药物中的用途,在血液的收集,循环和储存中使用的装置以及此类化​​合物的制备方法。

摘要

1. Aminobenzene and methoxyguandinas have the first-order equation or acceptable solution, hydrate or salt on drugs; in the case that R1 is one of the substrates of dec3-8, cyclopentyl, acyl pyridine, tar, arilo, aralquilo or isobutylene, either of them can be replaced; Z is - n10so2-n10 -;-NR10C (RYRZ) -,-C (RYRZ) NR10- OSO2--SO2O- -OC (RYRZ) -NR10CO- o -CONR10-Ry and RZ are independent hydrogen, tar, cyclopentyl, arilo, aralquilo, hydroxy,R2, R3 and R4 are independent hydrogen, tar, cyclopentadiene, alquenilo, tar, arilo arlquilo, allotype, trifluoromethyl, red leaf, hydrogen, cyanogen, nitrate, carbohydrate, co2rx, ch2orx or orx, Or when they are on the adjacent carbon atom, R2 and R3 can also form a de-ch = CH-CH = ch-o - (CH2) Q, where q is entr e e 2 and 6, R4 is defined as before; Rx is independent hydrogen in each case,cycloalkyl alkyl wherein said alkyl or cycloalkyl groups may optionally have one or more unsaturations; Y is one of -O-, NR10-, -S-, CHR1 0- or a covalent bond; R10, in each case, is independently one of hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoalkylaminoalkyl (C2-10) dialkylaminoalkyl (C2-10) carboxyalkyl; X is oxygen or NR9; R9 is one of hydrogen, alkyl, cycloalkyl or aryl, wherein said alkyl, cycloalkyl or aryl may be optionally substituted with amino, monoalkylamino, dialkylamino, alkoxy, hydroxy, carboxy, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarboyl nyl, aryl, heteroaryl, acylamino,Cyanogen or cyanogen trifluoride; n between 0 and 8; m in the middle
机译:1.氨苯和甲氧基胍具有一阶方程或药物上可接受的溶液,水合物或盐;在R1是dec3-8的底物之一的情况下,环戊基,酰基吡啶,焦油,芳基,芳基基或异丁烯可被替换; Z是-n10so2-n10-;-NR10C(RYRZ)-,-C(RYRZ)NR10- OSO2--SO2O- -OC(RYRZ)-NR10CO- o -CONR10-Ry和RZ是独立的氢,焦油,环戊基, arilo,alralquilo,羟基,R2,R3和R4是独立的氢,焦油,环戊二烯,alquenilo,焦油,arilo arlquilo,同种异型,三氟甲基,红叶,氢,氰,硝酸盐,碳水化合物,co2rx,ch2orx或orx,或当它们在相邻的碳原子上,R 2和R 3还可形成下式= CH-CH = ch-o-(CH 2)Q,其中q为2和6,R 4如前所述。 Rx在每种情况下都是独立的氢,是环烷基烷基,其中所述烷基或环烷基可任选具有一个或多个不饱和基; Y是-O-,NR10-,-S-,CHR1 0-或共价键之一;在每种情况下,R 10独立地为氢,烷基,芳烷基,芳基,羟烷基,氨基烷基,单烷基氨基烷基(C2-10),二烷基氨基烷基(C2-10)羧基烷基之一; X是氧或NR 9; R9是氢,烷基,环烷基或芳基之一,其中所述烷基,环烷基或芳基可任选地被氨基,单烷基氨基,二烷基氨基,烷氧基,羟基,羧基,烷氧基羰基,芳氧基羰基,芳烷氧基羰基基团,芳基,杂芳基,酰基氨基,氰基取代或三氟化氰; n在0到8之间;中间的米

著录项

  • 公开/公告号AR008327A1

    专利类型

  • 公开/公告日1999-12-29

    原文格式PDF

  • 申请/专利权人 3-DIMENSIONAL PHARMACEUTICALS INC.;

    申请/专利号AR1997P105565

  • 发明设计人

    申请日1997-11-26

  • 分类号C07C309/73;C07D295/22;A01N1/02;A61K;A61K31/155;A61K31/165;A61K31/18;A61K31/225;A61K31/255;A61K31/305;A61K31/335;A61K31/341;A61K31/36;A61K31/365;A61K31/38;A61K31/381;A61K31/395;A61K31/40;A61K31/44;A61K31/445;A61K31/4468;A61K31/47;A61K31/472;A61K31/495;A61K31/505;A61K31/506;A61K31/535;A61K33/42;A61L33;A61P7;A61P7/02;A61P7/04;A61P9/10;A61P29;C07C;C07C69/76;C07C279;C07C279/10;C07C281/16;C07C291/04;C07C303/30;C07C303/40;C07C305;C07C309;C07C309/63;C07C309/75;C07C309/76;C07C309/77;C07C311/08;C07C311/16;C07C311/17;C07C311/18;C07C311/19;C07C311/21;C07C317/14;C07C317/26;C07C323/17;C07D;C07D207/14;C07D207/16;C07D207/48;C07D209/04;C07D211/22;C07D211/58;C07D211/64;C07D211/96;C07D213/24;C07D213/42;C07D213/74;C07D215/12;C07D215/36;C07D217/12;C07D217/22;C07D229;C07D231/04;C07D237/02;C07D239/42;C07D239/72;C07D243/04;C07D245/02;C07D261/02;C07D263/54;C07D265/02;C07D267/04;C07D269;C07D285/14;C07D295/12;C07D307/02;C07D307/52;C07D307/66;C07D311/66;C07D311/74;C07D317/08;C07D317/14;C07D317/34;C07D317/40;C07D317/64;C07D333/06;C07D333/34;C07D333/54;C07D333/62;C07D403/04;C07D413/04;C07F9/22;

  • 国家 AR

  • 入库时间 2022-08-22 01:57:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号